Biotech

All Articles

Otsuka pays $800M for Jnana as well as its own clinical-stage PKU drug

.Otsuka Drug has gotten Boston-based Jnana Rehabs for $800 million so the Oriental biotech may get i...

FibroGen lays off 75% people personnel as resource fails 2 additional tests

.FibroGen is actually radically restructuring its organization, laying off 75% of its own united sta...

Tracon unwind full weeks after injectable PD-L1 inhibitor stop working

.Tracon Pharmaceuticals has actually decided to unwind functions full weeks after an injectable invu...

Ideaya bags alternative on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is wagering $400 million in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M loss on stopped working epilepsy medication, promotes FDA run

.Our company actually know that Takeda is actually wishing to find a course to the FDA for epilepsy ...

VBI Vaccinations files for bankruptcy, looks for resource purchase

.Immunology biotech VBI Injections is actually turning dangerously near the point of no return, alon...

Celldex anti-cKIT antibody reduce hives in an additional phase 2 research

.It is actually challenging to muscular tissue in on a room as affordable as immunology, yet Celldex...

Boehringer offers up to $1.3 B for gate prevention biotech

.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Rehabs and also a preclinical invulne...

Ventyx's last resort for inflamed med sides in Crohn's failing

.Ventyx Biosciences' Crohn's illness medicine did certainly not help individuals obtain remission in...

Cognition's period 2 sparkle records taint Alzheimer's possibility

.Cognition Therapeutics' phase 2 luster trial has actually taken a number of the gloss off the Alzhe...